News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arbor Vita Corporation Announces a Collaboration and License Agreement With Becton, Dickinson and Company (BDX) for the Development of a Diagnostic Test for Cervical Cancer



11/10/2008 12:26:52 PM

SUNNYVALE, CA--(Marketwire - November 10, 2008) - Arbor Vita Corporation (AVC), a privately held biopharmaceutical company, today announced a strategic collaboration in women's health with BD (Becton, Dickinson and Company), a leading global medical technology company. The collaboration and license agreement is initially focused on the development of a commercial diagnostic for cervical cancer, which globally affects more than 500,000 women each year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES